CENSO BIOTECHNOLOGIES LTD
A leading CRO with unparalleled expertise in intricate cell biology, focusing on human neurodegenerative, neuroinflammatory, and inflammatory disease models.
A leading CRO with unparalleled expertise in intricate cell biology, focusing on human neurodegenerative, neuroinflammatory, and inflammatory disease models.
Censo Bio is a leading Contract Research Organization (CRO) that specializes in intricate cell biology, particularly focusing on human neurodegenerative, neuroinflammatory, and inflammatory disease models. Founded in 2016, this specialist CRO has garnered attention for its unparalleled expertise in the biotechnology sector. Notably, the company received a significant £144.42KVenture Round investment on 17 April 2020, with funding from Par Equity, Ironbridge Capital Partners, and the Scottish Investment Bank. With its unique focus and recent investment backing, Censo Bio is poised for further growth and innovation in the biotechnology space.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | £144.42K | 3 |
|
17 Apr 2020 |
| Venture Round | £905.67K | 2 |
|
11 Mar 2020 |
| Venture Round | £800.00K | 2 |
|
23 Aug 2019 |
| Venture Round | £1.30M | 1 |
|
15 Oct 2018 |
No recent news or press coverage available for CENSO BIOTECHNOLOGIES LTD.
We care about your data, and we'd love to use cookies make your experience better.
